TCR2 Therapeutics
Utility Patent Applications
Last updated:
List of all TCR2 Therapeutics patents 11 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING TARGET SPECIFIC FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: ENGINEERED T CELLS FOR THE TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 22 Aug 2019 |
Showing 1 to 11 of 11 patents.